News | September 12, 2024
Merck launches single-use reactor to accelerate ADC manufacturing
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Merck shared updates on the company’s oncology pipeline and focused R&D approach
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Good momentum in commercial CDMO business
Subscribe To Our Newsletter & Stay Updated
